WallStreetZenWallStreetZen

NASDAQ: RCKT
Rocket Pharmaceuticals Inc Stock Ownership - Who owns Rocket Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rocket Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2025-05-20357$6.45
$2.30kSell
Jonathan David SchwartzChief Medical Gene Therapy Officer2025-05-20801$6.45
$5.16kSell
Martin WilsonGeneral Counsel2025-05-20587$6.45
$3.78kSell
Gaurav ShahCEO2025-05-202,253$6.45
$14.52kSell
Kinnari PatelPresident Head of RD and Chief Operating Officer2025-05-20767$6.45
$4.94kSell
Jonathan David SchwartzChief Medical Gene Therapy Officer2025-05-161,582$6.53
$10.33kSell
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2025-05-16655$6.53
$4.28kSell
Martin WilsonGeneral Counsel2025-05-16946$6.53
$6.18kSell
Kinnari PatelPresident Head of RD and Chief Operating Officer2025-05-161,409$6.53
$9.20kSell
Gaurav ShahCEO2025-05-163,621$6.53
$23.64kSell

1 of 4

RCKT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCKT insiders and whales buy or sell their stock.

RCKT Shareholders

What type of owners hold Rocket Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP31.20%33,617,724$98.50MInsider
Rtw Investments LP16.42%17,687,772$51.83MInstitution
Roderick Wong15.10%16,272,635$47.68MInsider
Wellington Management Group LLP11.72%12,626,491$37.00MInstitution
Blackrock Inc6.75%7,274,234$21.31MInstitution
Vanguard Group Inc6.14%6,617,784$19.39MInstitution
Maverick Capital Ltd4.83%5,199,218$15.23MInstitution
Westfield Capital Management Co LP4.47%4,820,701$14.12MInstitution
State Street Corp3.44%3,705,461$10.86MInstitution
Suvretta Capital Management LLC3.25%3,502,000$10.26MInstitution

1 of 3

RCKT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCKT59.15%40.85%Net SellingNet Buying
ABEO41.13%58.87%Net SellingNet Selling
AURA79.28%18.77%Net SellingNet Buying
ATXS80.89%19.11%
CRVS47.03%39.69%Net BuyingNet Buying
View Top Biotech Stocks

Rocket Pharmaceuticals Stock Ownership FAQ

Who owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals (NASDAQ: RCKT) is owned by 99.99% institutional shareholders, 69.07% Rocket Pharmaceuticals insiders, and 0.00% retail investors. Rtw Investments LP is the largest individual Rocket Pharmaceuticals shareholder, owning 33.62M shares representing 31.20% of the company. Rtw Investments LP's Rocket Pharmaceuticals shares are currently valued at $98.50M.

If you're new to stock investing, here's how to buy Rocket Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.